It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DYN’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DYN’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).
DYN (@Biotechnology) experienced а -2.74% price change this week, while RVMD (@Biotechnology) price change was -0.28% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.40%. For the same industry, the average monthly price growth was -6.10%, and the average quarterly price growth was -7.72%.
DYN is expected to report earnings on May 01, 2025.
RVMD is expected to report earnings on May 12, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
DYN | RVMD | DYN / RVMD | |
Capitalization | 1.36B | 7.27B | 19% |
EBITDA | -312.84M | -594.31M | 53% |
Gain YTD | -48.812 | -10.608 | 460% |
P/E Ratio | N/A | N/A | - |
Revenue | 0 | 742K | - |
Total Cash | 724M | 1.55B | 47% |
Total Debt | 24.9M | 86.7M | 29% |
DYN | RVMD | |
---|---|---|
RSI ODDS (%) | 2 days ago77% | N/A |
Stochastic ODDS (%) | 2 days ago76% | 2 days ago87% |
Momentum ODDS (%) | 2 days ago83% | 2 days ago83% |
MACD ODDS (%) | N/A | 2 days ago79% |
TrendWeek ODDS (%) | 2 days ago88% | 2 days ago75% |
TrendMonth ODDS (%) | 2 days ago89% | 2 days ago78% |
Advances ODDS (%) | 4 days ago86% | 4 days ago81% |
Declines ODDS (%) | 12 days ago88% | 6 days ago76% |
BollingerBands ODDS (%) | 2 days ago82% | 2 days ago84% |
Aroon ODDS (%) | 2 days ago83% | 2 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GUSH | 24.95 | 1.61 | +6.90% |
Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF | |||
XMLV | 61.14 | 1.08 | +1.80% |
Invesco S&P MidCap Low Volatility ETF | |||
RSBT | 16.82 | 0.05 | +0.30% |
Return Stacked Bonds & Managed Futs ETF | |||
VMOT | 26.25 | N/A | N/A |
EA Series Trust Alpha Architect Value Momentum Trend ETF | |||
DFCF | 41.91 | -0.06 | -0.14% |
Dimensional Core Fixed Income ETF |
A.I.dvisor indicates that over the last year, DYN has been loosely correlated with MRSN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then MRSN could also see price increases.
Ticker / NAME | Correlation To DYN | 1D Price Change % | ||
---|---|---|---|---|
DYN | 100% | +1.52% | ||
MRSN - DYN | 46% Loosely correlated | +4.13% | ||
CRNX - DYN | 46% Loosely correlated | -1.63% | ||
RNA - DYN | 44% Loosely correlated | -3.21% | ||
INZY - DYN | 44% Loosely correlated | +1.03% | ||
IGMS - DYN | 44% Loosely correlated | -4.26% | ||
More |
A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with IDYA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then IDYA could also see price increases.
Ticker / NAME | Correlation To RVMD | 1D Price Change % | ||
---|---|---|---|---|
RVMD | 100% | +0.18% | ||
IDYA - RVMD | 45% Loosely correlated | -1.90% | ||
ERAS - RVMD | 45% Loosely correlated | -2.04% | ||
RYTM - RVMD | 43% Loosely correlated | +1.45% | ||
KYMR - RVMD | 43% Loosely correlated | +2.75% | ||
DYN - RVMD | 42% Loosely correlated | +1.52% | ||
More |